维持阶段抗抑郁药物的策略:系统性审查和网络分析
Ziyi Pan1, Haonan Zhang1, Binghua Li1
1Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Journal of affective disorders
|May 27, 2025
概括
对于维持抑郁症,继续或减少抗抑郁剂剂量是预防复发的有效方法. 切换或增加剂量可能不太有利,需要进一步研究.
科学领域:
- 药理干预药理干预
- 心理健康研究 心理健康研究
- 临床试验分析
背景情况:
- 维持缓解在抑郁症管理中至关重要.
- 抗抑郁药物药物策略需要评估长期有效性.
研究的目的:
- 为了比较和排名抗抑郁药物治疗策略,抑郁维持.
- 评估剂量调整,切换和继续服用抗抑郁药物的有效性.
主要方法:
- 进行了随机对照试验 (RCT) 的网络元分析 (NMA).
- 搜索了多个数据库,包括MEDLINE,EMBASE,PsycINFO,CENTRAL,CINAHL,PubMed,以及科学网.
- 包括的研究比较了继续,减少,增加,切换或停止抗抑郁药的情况.
主要成果:
- 所有的活跃策略都在预防复发方面优于停止药物治疗.
- 继续使用相同的剂量 (RR 0.54) 和减少剂量 (RR 0.49) 显示出显著的疗效.
- 切换抗抑郁药显示中度疗效 (RR 0.64) 与较高的不良事件风险.
结论:
- 持续和减少抗抑郁剂剂量似乎是有效的,并且可以很好地容忍抑郁症的维持.
- 增加剂量并没有改善疗效,但导致更高的治疗中断.
- 由于研究数量有限,需要进一步研究.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
Antidepressant Drugs: Overview
389
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
389
Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
335
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
335
Electroconvulsive Therapy
29
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
29
Psychosis: Goals of Pharmacotherapy
113
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
113


